Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Infect Dis ; 65(2): 226-232, 2017 Jul 15.
Article in English | MEDLINE | ID: mdl-28387784

ABSTRACT

BACKGROUND: Subacute sclerosing panencephalitis (SSPE) is a fatal complication of measles. We reviewed California cases from 1998-2015 to understand risk factors for SPPE and estimate incidence. METHODS: SSPE cases had clinically compatible symptoms and measles antibody detection in cerebrospinal fluid (CSF) or medical record documentation of SSPE. Cases were identified though a state death certificate search, Centers for Disease Control and Prevention reports, or investigations for undiagnosed neurologic disease. Measles detection in CSF was performed by serology at the California Department of Public Health or at clinical laboratories. RESULTS: Seventeen SSPE cases were identified. Males outnumbered females 2.4:1. Twelve (71%) cases had a history of measles-like illness; all 12 had illness prior to 15 months of age. Eight (67%) children were exposed to measles in California. SSPE was diagnosed at a median age of 12 years (3-35 years), with a latency period of 9.5 years (2.5-34 years). Among measles cases reported to CDPH during 1988-1991, the incidence of SSPE was 1:1367 for children <5 years, and 1:609 for children <12 months at time of measles disease. CONCLUSIONS: SSPE cases in California occurred at a high rate among unvaccinated children, particularly those infected during infancy. Protection of unvaccinated infants requires avoidance of travel to endemic areas, or early vaccination prior to travel at age 6-11 months. Clinicians should be aware of SSPE in patients with compatible symptoms, even in older patients with no specific history of measles infection. SSPE demonstrates the high human cost of "natural" measles immunity.


Subject(s)
Measles/complications , Subacute Sclerosing Panencephalitis/epidemiology , Subacute Sclerosing Panencephalitis/etiology , Adolescent , Adult , Antibodies, Viral/cerebrospinal fluid , California/epidemiology , Child , Child, Preschool , Female , Humans , Incidence , Infant , Male , Measles/cerebrospinal fluid , Measles/virology , Measles Vaccine , Measles virus/immunology , Risk Factors , Sex Factors , Subacute Sclerosing Panencephalitis/cerebrospinal fluid , Subacute Sclerosing Panencephalitis/virology , Vaccination , Young Adult
2.
Pediatrics ; 120(2): 305-13, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17671056

ABSTRACT

BACKGROUND: Encephalitis is a complex, debilitating, and sometimes fatal neurologic condition to which children are especially prone. Mycoplasma pneumoniae, a common respiratory pathogen, has been implicated as an etiology of encephalitis. Evidence for recent or acute M. pneumoniae infection has been demonstrated in limited studies of both pediatric and adult patients with encephalitis. PATIENTS AND METHODS: Unexplained encephalitis cases are referred to the California Encephalitis Project for diagnostic testing. Serum, cerebrospinal fluid, and respiratory specimens are tested by polymerase chain reaction and serology methods for the presence of multiple pathogens, including M. pneumoniae. M. pneumonia-associated cases of encephalitis were compared with other bacterial agents, herpes simplex virus 1, and enterovirus. RESULTS: Of 1988 patients referred to the California Encephalitis Project, evidence of acute M. pneumoniae infection was found in 111 patients, of which 84 (76%) were pediatric patients. Eighty percent of the 84 patients were positive for M. pneumoniae by serology alone. Cerebrospinal fluid polymerase chain reaction for M. pneumoniae was rarely positive (2%). Patients with M. pneumoniae-associated pediatric encephalitis were a median of 11 years old, progressed rapidly (median: 2 days from onset to hospitalization), and were often in the ICU (55%). Symptoms included fever (70%), lethargy (68%), and altered consciousness (58%). Gastrointestinal (45%) and respiratory (44%) symptoms were less common. Compared with patients with other bacterial as well as viral agents, patients with M. pneumoniae-associated encephalitis had fewer seizures and less-severe hospital courses. CONCLUSIONS: M. pneumoniae is the most common agent implicated in the California Encephalitis Project. Patients with M. pneumoniae-associated encephalitis are predominantly pediatric, and their presentations are clinically similar to enterovirus encephalitis, although they frequently require intensive care with prolonged hospitalizations. Given that M. pneumoniae infection is found more than any other pathogen, increased emphasis should be placed on elucidating the role and mechanism of M. pneumoniae in encephalitis.


Subject(s)
Encephalitis/microbiology , Mycoplasma pneumoniae/isolation & purification , Mycoplasma pneumoniae/physiology , Pneumonia, Mycoplasma/microbiology , Adolescent , Adult , California/epidemiology , Child , Child, Preschool , Encephalitis/diagnosis , Encephalitis/epidemiology , Female , Humans , Infant , Male , Middle Aged , Pneumonia, Mycoplasma/diagnosis , Pneumonia, Mycoplasma/epidemiology
3.
Emerg Infect Dis ; 11(10): 1621-4, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16318710

ABSTRACT

An outbreak of myocarditis occurred among adults in Illinois in 2003. Diagnostic testing of myocardial tissues from 3 patients and comprehensive tests for enterovirus and adenovirus of other specimens from patients were inconclusive. Appropriate specimen collection from patients with idiopathic cardiomyopathy and further enhancement of diagnostic techniques are needed.


Subject(s)
Disease Outbreaks , Myocarditis/epidemiology , Adult , Aged , Female , Humans , Illinois/epidemiology , Male , Middle Aged , Myocarditis/etiology , Myocardium/pathology , Pericarditis/epidemiology , Seasons
SELECTION OF CITATIONS
SEARCH DETAIL
...